The LAMA* aclidinium bromide was similarly effective in reducing exacerbation rate without raising the risk of MACE** or all-cause mortality regardless of recent history of exacerbations in patients with moderate-to-very severe chronic obstructive pulmonary disease (COPD), according to a subgroup analysis of the phase IV ASCENT-COPD*** trial presented at the CHEST 2019 Annual Meeting.
Drinking soft drinks may be linked to asthma in adults and wheeze in children, according to a meta-analysis. Furthermore, prenatal maternal consumption of the drink can promote the development of inflammatory disease of the airways of the lungs in the offspring.
The lung damage acquired from smoking persists years after smoking cessation, with a faster decline in lung function in former smokers compared with never-smokers, according to a recent US-based study.
Consistent with clinical trial data, the use of biologic therapies significantly reduced asthma exacerbations in addition to having steroid-sparing effects in patients with severe, refractory asthma who were dependent on oral steroids, according to a real-world study presented at the annual CHEST Meeting 2019 held in New Orleans, Louisiana, US.
While adding varenicline to weekly counselling for smoking cessation did not improve abstinence rates among adolescent smokers at the end of treatment, it may promote earlier abstinence and sustained response to varenicline post-treatment, a study finds.
Higher cardiorespiratory fitness may result in lower healthcare expenditures among individuals with and without diabetes, a study has shown. In addition, the association between fitness and cost savings is particularly evident among those with diabetes.
Dr Ong Kian Chung, a respiratory specialist at the KC Ong Chest & Medical Clinic, Mount Elizabeth Medical Centre, Singapore spoke on the evils of tobacco use and how clinicians can help in smoking cessation.